Article Information
History
- April 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- James D. Byrne1,2,3,†,
- Adam J. Wentworth2,3,†,
- Peter R. Chai2,3,4,5,6,†,
- Hen-Wei Huang2,3,†,
- Sahab Babaee2,3,7,
- Canchen Li3,
- Sarah L. Becker2,7,
- Caitlynn Tov2,
- Soekkee Min7 and
- Giovanni Traverso2,3,7,*
- 1Harvard Radiation Oncology Program, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02114, USA
- 2Division of Gastroenterology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
- 3David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA
- 4Division of Medical Toxicology, Department of Emergency Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
- 5The Fenway Institute, Boston MA
- 6Department of Psychosocial Oncology and Palliative Care, Dana Farber Cancer Institute, Boston MA
- 7Department of Mechanical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, MA 02139, USA
- ↵*Corresponding author. E-mail: cgt20{at}mit.edu, ctraverso{at}bwh.harvard.edu (G.T.)
↵† These authors contributed equally to this work
Posted April 07, 2020.
Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection
